312 related articles for article (PubMed ID: 29486622)
1. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.
Belfiore A; Malaguarnera R; Nicolosi ML; Lappano R; Ragusa M; Morrione A; Vella V
Cell Adh Migr; 2018; 12(4):305-314. PubMed ID: 29486622
[TBL] [Abstract][Full Text] [Related]
2. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
3. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
[TBL] [Abstract][Full Text] [Related]
4. Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.
Vella V; Malaguarnera R; Nicolosi ML; Morrione A; Belfiore A
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118522. PubMed ID: 31394114
[TBL] [Abstract][Full Text] [Related]
5. DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.
Vella V; Giuliano M; Nicolosi ML; Majorana MG; Marć MA; Muoio MG; Morrione A; Maggiolini M; Lappano R; De Francesco EM; Belfiore A
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206590
[TBL] [Abstract][Full Text] [Related]
6. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells.
Avino S; De Marco P; Cirillo F; Santolla MF; De Francesco EM; Perri MG; Rigiracciolo D; Dolce V; Belfiore A; Maggiolini M; Lappano R; Vivacqua A
Oncotarget; 2016 Aug; 7(33):52710-52728. PubMed ID: 27384677
[TBL] [Abstract][Full Text] [Related]
8. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
Malaguarnera R; Nicolosi ML; Sacco A; Morcavallo A; Vella V; Voci C; Spatuzza M; Xu SQ; Iozzo RV; Vigneri R; Morrione A; Belfiore A
Oncotarget; 2015 Jun; 6(18):16084-105. PubMed ID: 25840417
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives.
Vella V; Malaguarnera R
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513575
[TBL] [Abstract][Full Text] [Related]
10. Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer.
Buraschi S; Morcavallo A; Neill T; Stefanello M; Palladino C; Xu SQ; Belfiore A; Iozzo RV; Morrione A
Matrix Biol Plus; 2020 May; 6-7():100022. PubMed ID: 33543020
[TBL] [Abstract][Full Text] [Related]
11. A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells.
Chen Z; Liu J; Chu D; Shan Y; Ma G; Zhang H; Zhang XD; Wang P; Chen Q; Deng C; Chen W; Dimitrov DS; Zhao Q
Int J Biol Sci; 2018; 14(7):799-806. PubMed ID: 29910690
[TBL] [Abstract][Full Text] [Related]
12. Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β
Baltes F; Caspers J; Henze S; Schlesinger M; Bendas G
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668815
[TBL] [Abstract][Full Text] [Related]
13. Diversity of insulin and IGF signaling in breast cancer: Implications for therapy.
Lero MW; Shaw LM
Mol Cell Endocrinol; 2021 May; 527():111213. PubMed ID: 33607269
[TBL] [Abstract][Full Text] [Related]
14. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
[TBL] [Abstract][Full Text] [Related]
15. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
17. Signaling by discoidin domain receptor 1 in cancer metastasis.
Gadiya M; Chakraborty G
Cell Adh Migr; 2018; 12(4):315-323. PubMed ID: 30187813
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
19. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.
Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R
J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of the Fetal Insulin Receptor in Hormone-refractory Breast Cancer.
Mathur T; Yee D
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34304271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]